|
|
Volumn 2, Issue 3, 2002, Pages 419-439
|
|
Recent progress in the development of anticancer agents
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3' DEAMINO 3' MORPHOLINOOXAUNOMYCIN;
6 [2 (DIMETHYLAMINO)ETHYLAMINO] 3 HYDROXY 7H INDENO[2,1 C]QUINOLIN 7 ONE;
AMINOPTERIN;
AMMINEDICHLORO(2 METHYLPYRIDINE)PLATINUM;
ANTINEOPLASTIC AGENT;
BBR 3464;
BUSULFAN;
CAMPTOTHECIN;
CARMUSTINE;
CHLORAMBUCIL;
CHLORMETHINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DACARBAZINE;
DIMETHYLBUSULFAN;
DOXORUBICIN;
LOMUSTINE;
LURTOTECAN;
MANNOMUSTINE;
MELPHALAN;
METHOTREXATE;
MITOMYCIN C;
OXALIPLATIN;
PENCLOMEDINE;
PLEVITREXED;
SATRAPLATIN;
SEMUSTINE;
TAUROMUSTINE;
UNINDEXED DRUG;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER GENETICS;
CANCER SURGERY;
CARCINOGENESIS;
CELL CYCLE;
CELL METABOLISM;
CHEMOPROPHYLAXIS;
CLINICAL OBSERVATION;
CLINICAL RESEARCH;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG SYNTHESIS;
DRUG TARGETING;
DRUG TOLERANCE;
ENZYME ACTIVITY;
HUMAN;
MALIGNANT NEOPLASTIC DISEASE;
METASTASIS;
MITOSIS;
MOLECULAR BIOLOGY;
MOUSE;
MULTIDRUG RESISTANCE;
NEPHROTOXICITY;
NEUROTOXICITY;
NONHUMAN;
OTOTOXICITY;
POSTOPERATIVE PERIOD;
REVERTANT;
REVIEW;
SIGNAL TRANSDUCTION;
|
|
EID: 0036080202
PISSN: 15680118
EISSN: None
Source Type: Journal
DOI: 10.2174/1568011024606389 Document Type: Review |
|
Times cited : (211)
|
|
References (171)
|
